CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C10804 | BRD-K26586614 | BRD-K26586614 | -- | -- | -- | Details |
| C10805 | BRD-K26591929 | BRD-K26591929 | -- | -- | -- | Details |
| C10806 | BRD-K26594332 | BRD-K26594332 | -- | -- | -- | Details |
| C10807 | BRD-K26603007 | BRD-K26603007 | -- | -- | -- | Details |
| C10808 | BRD-K26603252 | PD-153035 | -- | -- | -- | Details |
| C10809 | BRD-K26604645 | BRD-K26604645 | -- | -- | -- | Details |
| C10810 | BRD-K26606423 | BRD-K26606423 | -- | -- | -- | Details |
| C10811 | BRD-K26612358 | BRD-K26612358 | -- | -- | -- | Details |
| C10812 | BRD-K26619122 | BRD-K26619122 | -- | -- | thiocolchicoside | Details |
| C10813 | BRD-K26620362 | BRD-K26620362 | -- | -- | -- | Details |
| C10814 | BRD-K26622714 | BRD-K26622714 | -- | -- | -- | Details |
| C10815 | BRD-K26626929 | BRD-K26626929 | -- | -- | -- | Details |
| C10816 | BRD-K26631178 | BRD-K26631178 | -- | -- | -- | Details |
| C10817 | BRD-K26631510 | BRD-K26631510 | -- | -- | -- | Details |
| C10818 | BRD-K26634012 | tilmicosin | -- | -- | -- | Details |
| C10819 | BRD-K26634627 | BRD-K26634627 | -- | -- | -- | Details |
| C10820 | BRD-K26634905 | BRD-K26634905 | -- | -- | -- | Details |
| C10821 | BRD-K26636241 | BRD-K26636241 | -- | -- | -- | Details |
| C10822 | BRD-K26641843 | BRD-K26641843 | -- | -- | -- | Details |
| C10823 | BRD-K26644839 | BRD-K26644839 | -- | -- | -- | Details |
| C10824 | BRD-K26647686 | BRD-K26647686 | -- | -- | -- | Details |
| C10825 | BRD-K26652457 | BRD-K26652457 | -- | -- | -- | Details |
| C10826 | BRD-K26653603 | BRD-K26653603 | -- | -- | -- | Details |
| C10827 | BRD-K26654895 | BRD-K26654895 | -- | -- | -- | Details |
| C10828 | BRD-K26657438 | imiquimod | TLR7; TLR8 | TLR agonist; Interferon inducer | -- | Details |
| C10829 | BRD-K26663582 | BRD-K26663582 | -- | -- | -- | Details |
| C10830 | BRD-K26664453 | BRD-K26664453 | -- | -- | cytochalasin-b | Details |
| C10831 | BRD-K26666618 | BRD-K26666618 | -- | -- | -- | Details |
| C10832 | BRD-K26667087 | BRD-K26667087 | -- | -- | -- | Details |
| C10833 | BRD-K26667523 | TAK-733 | MAP2K1 | MEK inhibitor | -- | Details |
| C10834 | BRD-K26669427 | WR-216174 | -- | -- | -- | Details |
| C10835 | BRD-K26674531 | GR-235 | NR1H4 | FXR antagonist; Estrogen receptor agonist; Progesterone receptor agonist | -- | Details |
| C10836 | BRD-K26676775 | SA-1460192 | -- | -- | -- | Details |
| C10837 | BRD-K26680822 | BRD-K26680822 | -- | -- | -- | Details |
| C10838 | BRD-K26682747 | BRD-K26682747 | -- | -- | -- | Details |
| C10839 | BRD-K26684619 | BRD-K26684619 | -- | -- | -- | Details |
| C10840 | BRD-K26689527 | BRD-K26689527 | -- | -- | -- | Details |
| C10841 | BRD-K26693319 | BRD-K26693319 | -- | -- | -- | Details |
| C10842 | BRD-K26694002 | BRD-K26694002 | -- | -- | -- | Details |
| C10843 | BRD-K26694226 | BRD-K26694226 | -- | -- | -- | Details |
| C10844 | BRD-K26701552 | tegobuvir | -- | -- | -- | Details |
| C10845 | BRD-K26704304 | BRD-K26704304 | -- | -- | -- | Details |
| C10846 | BRD-K26708780 | BRD-K26708780 | -- | -- | -- | Details |
| C10847 | BRD-K26709432 | BRD-K26709432 | -- | -- | -- | Details |
| C10848 | BRD-K26712974 | VX-765 | CASP1 | Caspase inhibitor | -- | Details |
| C10849 | BRD-K26715911 | BRD-K26715911 | -- | -- | -- | Details |
| C10850 | BRD-K26720280 | BRD-K26720280 | -- | -- | -- | Details |
| C10851 | BRD-K26727724 | BRD-K26727724 | -- | -- | -- | Details |
| C10852 | BRD-K26733240 | BRD-K26733240 | -- | -- | -- | Details |
| C10853 | BRD-K26734305 | BRD-K26734305 | -- | -- | -- | Details |
| C10854 | BRD-K26738018 | BRD-K26738018 | -- | -- | -- | Details |
| C10855 | BRD-K26739552 | fenspiride | -- | -- | -- | Details |
| C10856 | BRD-K26748243 | BRD-K26748243 | -- | -- | -- | Details |
| C10857 | BRD-K26755359 | BRD-K26755359 | -- | -- | -- | Details |
| C10858 | BRD-K26756156 | BRD-K26756156 | -- | -- | cadmium-chloride | Details |
| C10859 | BRD-K26756394 | VE-821 | ATR | ATR kinase inhibitor | -- | Details |
| C10860 | BRD-K26758344 | BRD-K26758344 | -- | -- | -- | Details |
| C10861 | BRD-K26759399 | BRD-K26759399 | -- | -- | -- | Details |
| C10862 | BRD-K26760349 | HG-9-91-01 | -- | -- | -- | Details |
| C10863 | BRD-K26765362 | BRD-K26765362 | -- | -- | -- | Details |
| C10864 | BRD-K26766324 | BRD-K26766324 | -- | -- | -- | Details |
| C10865 | BRD-K26766547 | BRD-K26766547 | -- | -- | -- | Details |
| C10866 | BRD-K26767475 | BRD-K26767475 | -- | -- | -- | Details |
| C10867 | BRD-K26767874 | BRD-K26767874 | -- | -- | -- | Details |
| C10868 | BRD-K26772093 | BRD-K26772093 | -- | -- | -- | Details |
| C10869 | BRD-K26778237 | BRD-K26778237 | -- | -- | -- | Details |
| C10870 | BRD-K26779385 | BRD-K26779385 | -- | -- | -- | Details |
| C10871 | BRD-K26785978 | BRD-K26785978 | -- | -- | -- | Details |
| C10872 | BRD-K26786741 | BRD-K26786741 | -- | -- | -- | Details |
| C10873 | BRD-K26790127 | BRD-K26790127 | -- | -- | -- | Details |
| C10874 | BRD-K26792953 | BRD-K26792953 | -- | -- | -- | Details |
| C10875 | BRD-K26798591 | BRD-K26798591 | -- | -- | -- | Details |
| C10876 | BRD-K26799408 | BRD-K26799408 | -- | -- | -- | Details |
| C10877 | BRD-K26801045 | pipamperone | DRD2; HTR2A | Dopamine receptor antagonist | -- | Details |
| C10878 | BRD-K26807903 | aklomide | -- | -- | -- | Details |
| C10879 | BRD-K26809097 | BRD-K26809097 | -- | -- | -- | Details |
| C10880 | BRD-K26813314 | protoporphyrin-ix | HMOX1 | Heme oxygenase inhibitor | -- | Details |
| C10881 | BRD-K26815099 | BRD-K26815099 | -- | -- | -- | Details |
| C10882 | BRD-K26817071 | BRD-K26817071 | -- | -- | -- | Details |
| C10883 | BRD-K26818574 | BIX-01294 | EHMT2 | DNA methyltransferase inhibitor; Histone lysine methyltransferase inhibitor | -- | Details |
| C10884 | BRD-K26822808 | BRD-K26822808 | -- | -- | -- | Details |
| C10885 | BRD-K26823213 | GW-842166 | -- | -- | -- | Details |
| C10886 | BRD-K26826253 | BRD-K26826253 | -- | -- | -- | Details |
| C10887 | BRD-K26831771 | BRD-K26831771 | -- | -- | -- | Details |
| C10888 | BRD-K26833429 | costunolide | -- | -- | -- | Details |
| C10889 | BRD-K26835110 | BRD-K26835110 | -- | -- | -- | Details |
| C10890 | BRD-K26836050 | BRD-K26836050 | -- | -- | -- | Details |
| C10891 | BRD-K26838195 | AST-1306 | EGFR; ERBB2 | EGFR inhibitor | -- | Details |
| C10892 | BRD-K26840329 | BRD-K26840329 | -- | -- | -- | Details |
| C10893 | BRD-K26844643 | BRD-K26844643 | -- | -- | -- | Details |
| C10894 | BRD-K26849279 | SA-424936 | -- | -- | -- | Details |
| C10895 | BRD-K26850845 | BRD-K26850845 | -- | -- | -- | Details |
| C10896 | BRD-K26852477 | BRD-K26852477 | -- | -- | -- | Details |
| C10897 | BRD-K26857129 | BRD-K26857129 | -- | -- | -- | Details |
| C10898 | BRD-K26862028 | BRD-K26862028 | -- | -- | -- | Details |
| C10899 | BRD-K26862321 | BRD-K26862321 | -- | -- | -- | Details |
| C10900 | BRD-K26863634 | BIX-01338 | -- | -- | -- | Details |
| C10901 | BRD-K26863838 | BRD-K26863838 | -- | -- | -- | Details |
| C10902 | BRD-K26866198 | BRD-K26866198 | -- | -- | -- | Details |
| C10903 | BRD-K26872015 | BRD-K26872015 | -- | -- | -- | Details |